July 1 turns Montana's 10 mg adult-use edible into noncompliant stock

Montana has set a hard new limit for adult-use edibles. Effective July 1, 2026, a single serving in an edible marijuana product drops to 5 milligrams of THC from 10 milligrams, and the state has told licensees that products labeled above 5 milligrams per serving may not be sold after that date.

That is the whole story in practical terms. A product that could sit legally on an adult-use shelf in June can become unsellable in July if its serving size stays above the new threshold. The state’s June 11 newsletter from the Cannabis & Alcohol Regulation Division, the office that oversees licensed marijuana businesses, turned a future statutory change into an immediate operating deadline.

The timing is what makes this news now. Montana did not announce a long consultation or a distant transition. It reminded businesses of a July 1 statutory switch only weeks before it takes effect. For manufacturers, that means deciding what to do with finished stock, works-in-progress, packaging inventory, and product formulas. For dispensaries, it means checking what is already on shelves and in storage, changing purchase plans, and making sure staff do not sell noncompliant inventory after the deadline.

This is not a narrow paperwork issue. Edibles are built around serving assumptions. A gummy, chocolate square, mint, capsule, or drink is not only a recipe. It is a dose format, a label claim, a package layout, and a retail instruction. When the legal serving size is cut in half, every part of that chain is affected.

Montana’s own implementation message is unusually direct. It does not merely say that future products should comply. It says products labeled above 5 milligrams per serving may not be sold after July 1. That language matters because it pushes the rule from product development into inventory control. Operators are not only being told what to make next. They are being told what cannot remain in commerce.

The same state update also points licensees to revised warning language for exit packaging, the outer package a consumer leaves the store with. That means the edible serving-size reset lands at the same time as another packaging task. In a large market with long planning cycles, that would still be disruptive. In a smaller state market, where many operators carry lean teams and tighter working capital, the deadline is sharper.

The law halves the legal serving size and pairs it with new warning rules

The legal backbone for the change sits in Montana’s dispensary statute. The law currently allows a 10 milligram single serving for an edible marijuana product in the adult-use market, but a future-dated version takes effect on July 1, 2026 and lowers that single serving to 5 milligrams of THC.

That may sound like a small textual revision, but the commercial meaning is larger. A “single serving” is the amount the state recognizes as one adult-use dose in that product. In practice, that affects how a product is formulated, how it is portioned, how the amount is stated on the label, and how a retailer explains it at the counter. If one gummy is labeled as containing 10 milligrams and one gummy is the serving, the product falls on the wrong side of the line after July 1. If a pack is arranged so that each distinct serving is 5 milligrams, it can fit the new standard if the rest of the package and labeling also comply.

This is an important distinction because the change is about serving size, not simply about whether a package contains THC. A product may still contain multiple servings. What matters first is the amount attached to each serving. That is why manufacturers cannot treat the issue as a routine sticker update unless the underlying product format and serving structure already fit the new rule.

The statute also keeps a separate lane for registered medical marijuana cardholders. Montana law states that those registered patients may buy higher-potency products. In plain terms, the state is not banning stronger edible doses across the entire legal system. It is narrowing them in the adult-use channel while preserving broader access in the medical channel.

That separation is central to understanding the policy design. Montana is using dosage rules to draw a firmer line between general retail sales and patient access. Adult-use consumers get the stricter serving standard. Medical patients remain eligible for products above it, subject to the medical system’s own requirements.

The regulator’s June 11 newsletter adds the operational instruction. It says that products labeled above 5 milligrams per serving may not be sold after July 1. It also flags revised warning requirements for exit packaging. Exit packaging is the outer bag, pouch, or container used when a customer leaves the dispensary. Warning statements on that packaging are not cosmetic. They are compliance text that retailers and brands need to keep current.

Pairing the serving-size change with packaging-warning changes creates a combined implementation problem. A business may need to adjust the formula, the way servings are defined, the principal display information on the product, and the warning language on the outer package at the same time. Old inventory can become stale in more than one way.

Some public questions remain. The state’s published materials are clear that adult-use products labeled above 5 milligrams per serving cannot be sold after July 1. They are less explicit, at least in the materials cited here, about how much flexibility exists for relabeling legacy stock, how noncompliant inventory should be handled if it cannot be sold through in time, and how easily products can be redirected between adult-use and medical channels. Those are not abstract legal questions. They are shop-floor questions about destruction, transfer, packaging, and timing.

Shelf management, reformulation, and medical segregation now move to the center

The first businesses hit by the deadline are edible manufacturers and dispensaries. Cultivators matter to the supply chain, but this particular change lands downstream, where THC is portioned into consumer units and offered for sale.

For manufacturers, the problem starts with product architecture. Many edible lines are built around dose conventions that have been stable long enough to shape recipes, molds, cutting patterns, and package counts. A company selling a 10 milligram gummy as one serving now has a narrow window to decide whether to split that serving into smaller pieces, cut the dose per piece, redesign the package, shift the product into a medical-only format if allowed, or discontinue the stock. None of those options is frictionless.

Reformulation carries direct cost. Packaging changes carry cost. So does stranded inventory, which is stock that was produced legally but can no longer be sold in its current form once the rule changes. For smaller brands, the packaging issue can be as painful as the formula issue. Printed pouches, cartons, inserts, and warning materials are purchased in batches. A sudden change can turn that inventory into waste.

Dispensaries face a different but equally immediate set of tasks. They have to audit current inventory by serving size, stop reordering products that will age into noncompliance, create sell-through plans for items that are still legal before the deadline, and train staff on what changes July 1. Retail staff need to understand the difference between total THC in a package and THC per serving, because the new restriction is attached to the serving. That distinction is easy to blur at the counter and costly to mishandle.

There is also a customer communication problem. Consumers who are used to buying a 10 milligram single-serving edible may see replacement products that look similar but behave differently. Some products may move to more pieces per package with 5 milligrams in each piece. Others may simply come in weaker total-package formats. The cited state materials do not present this as a consumer education campaign, but that is effectively what the retail floor becomes in the first days of July.

Medical businesses are affected in a more complicated way. Because registered cardholders may buy higher-potency products, the medical channel could become more important for brands that want to preserve stronger edible formats. That does not mean demand automatically shifts there. Adult-use consumers are not medical patients by default, and the medical system has its own entry requirements. But the rule does make product segmentation more valuable. Operators with both adult-use and medical capabilities may be better positioned to sort product lines by channel.

For compliance teams and packaging suppliers, the simultaneous warning-language update matters almost as much as the 5 milligram cutoff. Businesses often treat dosage changes and warning changes as separate workstreams. Montana is forcing them together. That increases the chance of rushed artwork approvals, mismatched stock, and preventable store-level errors.

For investors and policy watchers, this is not a growth headline. It is a margin and execution headline. It says more about the internal discipline of operators than about the overall size of the market. The businesses that manage inventory tightly, keep packaging runs flexible, and maintain clear separation between adult-use and medical products are likely to absorb the shift more cleanly. Businesses that let product sit too long or depend on a small number of higher-dose adult-use stock keeping units could feel the change faster.

There is also a broader policy signal inside the number. A 5 milligram serving standard is materially more restrictive than a 10 milligram standard for general adult-use sales. Even without a detailed rationale in the cited materials, the practical effect is plain: Montana is lowering the amount of THC the general retail market can present as one serving. That changes product design and consumer pacing at the same time.

Montana is redefining the standard retail dose, not just revising a label

The most important point is that Montana is not merely editing compliance language. It is resetting the unit around which adult-use edible retail operates.

A legal serving size is one of the quiet foundations of a cannabis market. It shapes what manufacturers make, what dispensaries stock, how staff explain products, and how consumers calibrate use. When that unit is cut from 10 milligrams to 5 milligrams, the consequences reach further than the label panel. The state is telling the market what a normal adult-use edible portion should be.

The medical exception sharpens that message. Higher-potency products are not disappearing from the legal system altogether. They are being pushed out of ordinary adult-use retail and held inside the patient channel. That is a choice about market structure as much as dosage. It separates general access from higher-intensity formats more clearly than before.

The short implementation window makes the rule feel harder than the number alone suggests. A dose standard can be absorbed over time if contracts, packaging runs, and store inventories are allowed to run down naturally. Montana’s June reminder did not offer that kind of glide path. By warning that products labeled above 5 milligrams per serving may not be sold after July 1, the state converted a statute into a shelf deadline.

That is usually the moment when regulation stops looking theoretical. Operators have to count units, freeze purchase orders, decide what is worth remaking, and accept losses on what is not. Retailers have to turn legal text into point-of-sale discipline. Packaging vendors and compliance staff have to move faster than they would choose.

If the transition is orderly, Montana’s adult-use market will adapt quickly and 5 milligrams will become the new standard reference point for edible design. If it is messy, the disruption will not come from consumer demand suddenly disappearing. It will come from the ordinary mechanics of compliance, inventory age, and packaging timing.

That is why this matters beyond one state and one product category. Cannabis rules often look narrow on paper. The ones that move serving definitions are rarely narrow in practice. Montana has chosen to make dosage policy visible at the shelf edge, and by July 1 the market has to be ready for it.